Published in Biochemistry on February 10, 2004
Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J (2005) 1.01
Synuclein modulation of monoamine transporters. FEBS Lett (2011) 1.01
Fluorescent avidin-bound silver particle: a strategy for single target molecule detection on a cell membrane. Anal Chem (2009) 0.95
Partial regulation of serotonin transporter function by gamma-synuclein. Neurosci Lett (2009) 0.84
Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PLoS One (2013) 0.83
Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl. J Neural Transm (Vienna) (2005) 0.81
Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking. PLoS One (2013) 0.78
Target molecule imaging on tissue specimens by fluorescent metal nanoprobes. J Biomed Opt (2011) 0.78
Bioreactor-Based Online Recovery of Human Progenitor Cells with Uncompromised Regenerative Potential: A Bone Tissue Engineering Perspective. PLoS One (2015) 0.77
Alpha-synuclein modulates dopamine neurotransmission. J Chem Neuroanat (2016) 0.75
Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol (2010) 2.13
Differential expression of D2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J Hypertens (2003) 1.58
Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett (2003) 1.42
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J (2009) 1.42
Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease. ChemMedChem (2006) 1.37
Preliminary observations on the spawning conditions of the European amphioxus (Branchiostoma lanceolatum) in captivity. J Exp Zool B Mol Dev Evol (2004) 1.33
Insights into spawning behavior and development of the European amphioxus (Branchiostoma lanceolatum). J Exp Zool B Mol Dev Evol (2007) 1.29
Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell (2003) 1.28
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J (2004) 1.26
The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res (2004) 1.25
An inflammatory pathomechanism for Parkinson's disease? Curr Med Chem (2006) 1.20
Slow oscillations in two pairs of dopaminergic neurons gate long-term memory formation in Drosophila. Nat Neurosci (2012) 1.17
Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease. Eur J Neurosci (2011) 1.14
Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry (2005) 1.14
alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett (2004) 1.14
The evolution of dopamine systems in chordates. Front Neuroanat (2011) 1.11
Dopamine inhibits luteinizing hormone synthesis and release in the juvenile European eel: a neuroendocrine lock for the onset of puberty. Biol Reprod (2004) 1.09
Two tyrosine hydroxylase genes in vertebrates New dopaminergic territories revealed in the zebrafish brain. Mol Cell Neurosci (2010) 1.08
Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J (2003) 1.07
Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. FASEB J (2006) 1.06
Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci (2006) 1.04
A phylotypic stage in vertebrate brain development: GABA cell patterns in zebrafish compared with mouse. J Comp Neurol (2006) 1.03
Synuclein modulation of monoamine transporters. FEBS Lett (2011) 1.01
Androgen-dependent stimulation of brain dopaminergic systems in the female European eel (Anguilla anguilla). Endocrinology (2006) 1.01
The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci (2004) 1.00
Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein. Eur J Neurosci (2006) 0.99
The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells. Neurotox Res (2006) 0.99
D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J Biol Chem (2004) 0.98
Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. PLoS One (2011) 0.98
The role of alpha-synuclein in both neuroprotection and neurodegeneration. Ann N Y Acad Sci (2004) 0.97
Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways. PLoS One (2012) 0.97
Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity. Mol Cell Neurosci (2003) 0.96
Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology (2008) 0.96
NR4A2 controls the differentiation of selective dopaminergic nuclei in the zebrafish brain. Mol Cell Neurosci (2008) 0.95
Differential expression of dopaminergic cell markers in the adult zebrafish forebrain. J Comp Neurol (2011) 0.94
Secondary neurogenesis in the brain of the African clawed frog, Xenopus laevis, as revealed by PCNA, Delta-1, Neurogenin-related-1, and NeuroD expression. J Comp Neurol (2005) 0.94
Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. Eur J Neurosci (2007) 0.94
Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res (2010) 0.93
Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. Eur J Neurosci (2009) 0.92
Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons. J Neurochem (2008) 0.91
Dopamine receptors for every species: gene duplications and functional diversification in Craniates. J Struct Funct Genomics (2003) 0.89
Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis. Neurosci Lett (2004) 0.89
Pitx genes in Tunicates provide new molecular insight into the evolutionary origin of pituitary. Gene (2002) 0.88
Distribution of tyrosine hydroxylase, dopamine, and serotonin in the central nervous system of amphioxus (Branchiostoma lanceolatum): implications for the evolution of catecholamine systems in vertebrates. J Comp Neurol (2004) 0.87
Inflammation and Parkinson's disease. Curr Drug Targets Inflamm Allergy (2002) 0.87
Phylotypic expression of the bHLH genes Neurogenin2, Neurod, and Mash1 in the mouse embryonic forebrain. J Comp Neurol (2010) 0.87
Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry (2004) 0.87
The dopamine-synthesizing cells in the swimming larva of the tunicate Ciona intestinalis are located only in the hypothalamus-related domain of the sensory vesicle. Eur J Neurosci (2005) 0.86
Partial regulation of serotonin transporter function by gamma-synuclein. Neurosci Lett (2009) 0.84
Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells. Neurosci Lett (2004) 0.84
Regulatory gene expressions in the ascidian ventral sensory vesicle: evolutionary relationships with the vertebrate hypothalamus. Dev Biol (2005) 0.84
Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation. Mol Cell Neurosci (2004) 0.83
Emotions and motivated behavior converge on an amygdala-like structure in the zebrafish. Eur J Neurosci (2014) 0.83
Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity. J Biol Chem (2003) 0.83
Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PLoS One (2013) 0.83
Cloning and developmental expression patterns of Dlx2, Lhx7 and Lhx9 in the medaka fish (Oryzias latipes). Mech Dev (2004) 0.83
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease. BMC Neurosci (2011) 0.83
Dopamine inhibits reproduction in female zebrafish (Danio rerio) via three pituitary D2 receptor subtypes. Endocrinology (2013) 0.82
A quantitative real-time RT-PCR assay for European eel tyrosine hydroxylase. Gen Comp Endocrinol (2005) 0.82
Evolution of dopamine receptor genes of the D1 class in vertebrates. Mol Biol Evol (2012) 0.82
Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson's disease. Biochem Biophys Res Commun (2007) 0.82
Dopamine D1 receptor-mediated toxicity in human SK-N-MC neuroblastoma cells. Neurochem Int (2005) 0.81
Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with alpha-synuclein and its familial Parkinson's disease-linked mutants. Neurosci Lett (2003) 0.81
Morphological and gene expression similarities suggest that the ascidian neural gland may be osmoregulatory and homologous to vertebrate peri-ventricular organs. Eur J Neurosci (2006) 0.81
Two distinct dopamine D2 receptor genes in the European eel: molecular characterization, tissue-specific transcription, and regulation by sex steroids. Endocrinology (2008) 0.81
Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens (2005) 0.80
Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum. Neurosci Lett (2009) 0.80
Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases. PLoS One (2013) 0.79
Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization. J Neurochem (2002) 0.79
Delineation of the conserved functional properties of D1A, D1B and D1C dopamine receptor subtypes in vertebrates. Biol Cell (2004) 0.78
Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking. PLoS One (2013) 0.78
Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive rat. Clin Exp Hypertens (2003) 0.78
Monoaminergic modulation of photoreception in ascidian: evidence for a proto-hypothalamo-retinal territory. BMC Biol (2012) 0.77
Classification of Dopamine Receptor Genes in Vertebrates: Nine Subtypes in Osteichthyes. Brain Behav Evol (2015) 0.76
Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies. Exp Neurol (2007) 0.76
Role of Dopaminergic D2 Receptors in the Regulation of Glutamic Acid Decarboxylase Messenger RNA in the Striatum of the Rat. Eur J Neurosci (1992) 0.76
Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation. Brain Res (2003) 0.75
[An antagonist to GnRH in the control of reproduction in teleost fish: dopaminergic inhibition. Ancestral origin and differential conservation within vertebrates?]. J Soc Biol (2004) 0.75
Introduction to the Proceedings of the Fifth European Conference on Comparative Neurobiology: evolution and the generation of novelties in the nervous system. Brain Res Bull (2007) 0.75